Publications

Search our bibliography using the filters on the right-hand side.

Displaying 101 through 130 of 130 publications.

Wolowacz SE, Hess N, Brennan VK, Monz BU, Plumb JM. Cost-effectiveness of venous thromboembolism prophylaxis in total hip and knee replacement surgery: the evolving application of health economic modelling over 20 years. Curr Med Res Opin. 2008 Oct 1;24(10):2993-3006.

Brennan VK, Wolowacz SE. A systematic review of breast cancer utility weights. Poster presented at the 2008 ISPOR 13th Annual International Meeting; May 7, 2008. [abstract] Value Health. 2008 May; 11(3):A77.

Wolowacz SE, Cameron DA, Tate HC, Bagust A. Docetaxel in combination with doxorubicin and cyclophosphamide as adjuvant treatment for early node-positive breast cancer: a cost-effectiveness and cost-utility analysis. J Clin Oncol. 2008 Feb 20;26(6):925-33.

Wolowacz SE, Roskell N, Kelly S, Maciver FM, Brand CS. Cost effectiveness of pegaptanib for the treatment of age-related macular degeneration in the UK. Pharmacoeconomics. 2007 Oct 1;25(10):863-79.

Javitt JC, Wolowacz SE, Roskell NS, Maciver F, Pleil A, Zlateva G. Balancing visual acuity benefits with systemic adverse effects in anti-VEGF therapy. Poster presented at the ARVO 9th Annual Meeting; May 2007; May 2007. Fort Lauderdale, FL.

Wolowacz SE. Economic analysis of macugen for age-related macular degeneration. Poster presented at the Royal College of Surgeons; February 2, 2007. London, England.

Wolowacz SE, Khan SB. The New National Institute of Health and Clinical Excellence (NICE) Single Technology Appraisal (STA) process: experience from the first completed appraisals. Ispor Connections. 2007;13(2):12-5.

McCrink L, Allen RP, Wolowacz SE, Sherrill B, Connolly M, Kirsch J. Predictors of health-related quality of life in sufferers with restless legs syndrome: a multi-national study. Sleep Med. 2007 Jan 1;8(1):73-83.

Javitt JC, Wolowacz SE, Roskell NS, Maciver F, Kelly S, Pleil AM, Zlateva GP. Cost-effectiveness of pegaptanib in age-related macular degeneration: the impact of differences between USA and UK health care systems. Poster presented at the 2006 ISPOR 9th Annual European Congress; October 31, 2006. [abstract] Value Health. 2006 Nov; 9(6):A370.

Wolowacz SE, Roskell NS, Maciver F, Kelly S. Cost-utility analysis for pegaptanib in age-related macular degeneration in the UK: the impact of demographic and disease characteristics. Poster presented at the 2006 ISPOR 9th Annual European Congress; October 31, 2006. [abstract] Value Health. 2006 Nov; 9(6):A370.

Wolowacz SE. The National Institute for Health and Clinical Excellence (NICE) Single Technology Appraisal (STA) process: an update on the first round of submissions. Poster presented at the 2006 ISPOR 9th Annual European Congress; October 31, 2006.

Sculpher M, Longson C, Wolowacz SE, Khan S. The new National Institute of Health And Clinical Excellence (NICE) Single Technology Appraisal (STA) process: experience from the first round of completed appraisals. Poster presented at the 2006 ISPOR 9th Annual European Congress; October 28, 2006. Copenhagen, Denmark.

Sculpher M, Longson C, Wolowacz SE, Khan S. The new National Institute of Health And Clinical Excellence (NICE) Single Technology Appraisal (STA) process: experience from the first round of submissions. Poster presented at the 2006 ISPOR 11th Annual International Meeting; May 2006. Philadelphia, PA.

Longson C, Wolowacz SE, Sculpher MJ, Khan SB. The National Institute of Health and Clinical Excellence (NICE) Single Technology Appraisal (STA) process: an update on the first round of submission. Presented at the 2006 ISPOR 11th Annual International Meeting; May 2006. Philadelphia, PA.

Wolowacz SE, Roskell NS, Christie A, Kerr G, Cameron D. The cost of hospital care for relapsed breast cancer in the UK based on a large patient-level resource utilisation dataset. Poster presented at the 2005 ISPOR 8th Annual European Congress; November 10, 2005. Florence, Italy.

Wolowacz SE, Roskell NS, Christie A, Kerr G, Cameron D. Per-patient cost of hospital care for advanced breast cancer in the UK based on a large patient-level resource utilisation dataset. Poster presented at the 2005 ISPOR 8th Annual European Congress; November 2005. Florence, Italy. [abstract] Value Health. 2005 Nov; 8(6):A42.

Gaffney L, Sherrill EH, Wolowacz SE, Allen R, Connolly M. Predictors of health-related quality of life (HRQoL) in US patients suffering from rls. Poster presented at the International Congress on Parkinson's Disease and Movement Disorders; 2005.

Gaffney L, Sherrill B, Wolowacz SE, Allen R, Connolly M, Kirsch J. Evaluating the predictors of health-related quality of life in European respondents with restless legs syndrome. Poster presented at the ICPD meeting; 2005; 2005. Berlin, Germany.

Nicholls TJ, Carpenter BG, Rogers DJ, Cook DJ, Wolowacz SE, Smart JD. An investigationn of lectin binding sites on unfixed corneal and conjunctival surfaces of rats. Poster presented at the Proceedings of IinterLec; 2004.

Smart JD, Nicholls TJ, Green KL, Rogers DJ, Cook JD, Wolowacz SE. Lectins in drug delivery: an in vivo toxicity study of the lectins from Solanum tuberosum and Helix pomatia. J Pharm Pharmacol. 1998 Sep.

Nicholls TJ, Cook DJ, Rogers DJ, Wolowacz SE, Smart JD. An investigation of lectin toxicity with cultured human conjunctival epithelial cells; lectins: biology biochemistry. Clin Chem. 1996;11:273-6.

Nicholls TJ, Green KL, Cook DJ, Rogers DJ, Wolowacz SE, Smart JD. An investigation of lectins for use in ophthalmic drug delivery. Int J Pharm. 1996;138(2):175-83.

McTaggart S, Anderson M, Wolowacz SE. Development of a tissue engineered ligament replacement. Poster presented at the 5th World Biomaterials Congress; 1996. Toronto, Canada.

Doyle V, Pearson R, Wolowacz SE, McTaggart S. An investigation of the growth of human dermal fibroblasts on poly-l-lactic acid in vitro. Presented at the European Society for Biomaterials Meeting; 1995. Porto, Portugal.

Nicholls TJ, Cook DJ, Rogers DJ, Wolowacz SE, Smart JD. An investigation of lectin binding sites within the precorneal region. J Pharm Pharmacol. 1994;46:1050.

Nicholls TJ, Cook JD, Rogers DJ, Wolowacz SE, Smart JD. The effect of exposure time and washing on the binding of two lectins to tissues from the precorneal region of rats. Poster presented at the British Pharmaceutical Society; 1994.

Wolowacz SE, Hamid O, Jones D, Lazare R. Ocular bioavailability of topical triamterene in the conscious rabbit by a non-invasive method. Poster presented at the British Toxicology Society meeting; April 1992. York, United Kingdom.

Wolowacz SE, Yon Hin BFY, Lowe CR. Covalent electropolymerisation of glucose oxidase in polypyrrole. Anal Chem. 1992;64(14):1541.

Lowe CR, Foulds NC, Wolowacz SE, Yon Hin BFY. Enzyme entrapment in conducting polymers, application to amperometric biosensors. London: United Kingdom. Springer Series in Solid State Sciences; 1991.

Wolowacz SE, Yon Hin BFY, Lowe CR. Covalent electropolymerisation of glucose oxidase in polypyrrole. Poster presented at the 3rd International Conference of Chemical Sensors; 1990. Cleveland, OH.